Effect of Locally Applied WEB 2086, a Platelet-activating Factor Antagonist, on Inflammatory Skin Conditions in Mice

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 1996 Jul 1

PMID 8844132

Authors

L Kemeny

V Trach

A Dobozy

Affiliations

Soon will be listed here.

References

Archer C, Page C, Morley J, Macdonald D . Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br J Dermatol. 1985; 112(3):285-90. DOI: 10.1111/j.1365-2133.1985.tb04855.x. View

Grandel K, Farr R, Wanderer A, Eisenstadt T, Wasserman S . Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med. 1985; 313(7):405-9. DOI: 10.1056/NEJM198508153130702. View

Shukla S . Platelet-activating factor receptor and signal transduction mechanisms. FASEB J. 1992; 6(6):2296-301. DOI: 10.1096/fasebj.6.6.1312046. View

MUACEVIC G, Weber K . Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharmacol Exp Ther. 1987; 241(3):974-81. View

Hunyadi J, Kenderessy A, Duda E, Braquet P, Dobozy A . Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells. Mol Immunol. 1993; 30(6):517-9. DOI: 10.1016/0161-5890(93)90025-7. View

Gomez-Cambronero J, Wang E, Johnson G, Huang C, Shaafi R . Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem. 1991; 266(10):6240-5. View

Braquet P, Touqui L, Shen T, Vargaftig B . Perspectives in platelet-activating factor research. Pharmacol Rev. 1987; 39(2):97-145. View

Mallet A, Cunningham F . Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun. 1985; 126(1):192-8. DOI: 10.1016/0006-291x(85)90590-x. View

Kemeny L, Csato M, Dobozy A . Pharmacological studies on dithranol-induced irritative dermatitis in mice. Arch Dermatol Res. 1989; 281(5):362-5. DOI: 10.1007/BF00412983. View

10.

Csato M, Czarnetzki B . Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. Br J Dermatol. 1988; 118(4):475-9. DOI: 10.1111/j.1365-2133.1988.tb02455.x. View

11.

Kemeny L, Ruzicka T, Braun-Falco O . Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol. 1990; 3(1):1-20. DOI: 10.1159/000210836. View

12.

OFlaherty J, Nishihira J . Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. J Immunol. 1987; 138(6):1889-95. View

13.

Calignano A, Cirino G, Meli R, Persico P . Isolation and identification of platelet-activating factor in UV-irradiated guinea pig skin. J Pharmacol Methods. 1988; 19(1):89-91. DOI: 10.1016/0160-5402(88)90049-6. View

14.

Au B, Williams T, Collins P . Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. J Immunol. 1994; 152(11):5411-9. View